#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17300	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2562	835.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1967	1967	T	1133	T,G,C	1127,5,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17300	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2562	835.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1701	1701	C	1085	C	1085	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17300	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2562	835.4	0	HET	.	.	.	G176C	.	176	176	G	693	693	G	1015	G,C	756,259	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29948	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	938.1	0	.	n	.	0	T695C	SNP	695	695	T	1273	1273	C	1154	C,T,G	1152,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29948	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	938.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2216	2216	G	1097	G,C	1095,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29948	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	938.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2549	2549	C	1043	C,T,A,G	1038,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29948	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	938.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2623	2623	A	1026	A	1026	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29948	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	938.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3175	3175	C	1081	C	1081	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2458	folP	852	852	100.0	folP.l15.c4.ctg.1	2069	148.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1291	1293	CGC	254;253;258	C,A;G;C	253,1;253;258	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5362	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3834	174.7	1	SNP	p	S91F	0	.	.	271	273	TCC	831	833	TCC	208;205;205	T;C;C	208;205;205	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5362	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3834	174.7	1	SNP	p	D95N	0	.	.	283	285	GAC	843	845	GAC	206;212;213	G,C;A;C	205,1;212;213	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5362	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3834	174.7	1	SNP	p	D95G	0	.	.	283	285	GAC	843	845	GAC	206;212;213	G,C;A;C	205,1;212;213	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2364	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1795	164.6	1	SNP	p	G45D	1	.	.	133	135	GAC	701	703	GAC	254;256;253	G;A;C	254;256;253	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1198	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1469	101.8	0	.	n	.	0	T10C	SNP	10	10	T	624	624	C	223	C	223	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1198	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1469	101.8	0	.	n	.	0	A197.	DEL	197	197	A	810	810	A	243	A	242	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1836	1838	GCA	255;254;254	G,A;C;A,T,C	254,1;254;252,1,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2319	2321	ATT	270;271;270	A;T;T,C	270;271;268,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	1	SNP	p	D86N	0	.	.	256	258	GAC	789	791	GAC	242;241;240	G;A;C	242;241;240	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	1	SNP	p	S87I	0	.	.	259	261	AGT	792	794	AGT	239;238;233	A,C;G;T	238,1;238;233	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	1	SNP	p	S87W	0	.	.	259	261	AGT	792	794	AGT	239;238;233	A,C;G;T	238,1;238;233	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	1	SNP	p	S87R	0	.	.	259	261	AGT	792	794	AGT	239;238;233	A,C;G;T	238,1;238;233	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5170	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3397	190.1	1	SNP	p	S88P	0	.	.	262	264	TCC	795	797	TCC	232;233;236	T;C;C	232;233;236	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4802	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3064	195.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1758	1760	GGC	277;280;279	G;G;C,T	277;280;278,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1491	1493	GCA	310;311;313	G;C;A	310;311;313	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1494	1496	ATC	314;313;313	A;T,A;C	314;312,1;313	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1506	1508	GTG	314;314;316	G;T,C;G,T	314;313,1;315,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1506	1508	GTG	314;314;316	G;T,C;G,T	314;313,1;315,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2010	2012	ACC	317;317;316	A,G;C;C,T	316,1;317;315,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2064	2066	GCG	306;308;307	G,C;C,T;G	305,1;307,1;307	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2064	2066	GCG	306;308;307	G,C;C,T;G	305,1;307,1;307	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2187	2189	GGT	312;310;310	G;G;T,C	312;310;309,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2196	2198	GGC	311;311;310	G;G;C,T	311;311;309,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5482	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2818	242.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2214	2216	CCG	310;308;309	C,A,T;C,A;G	307,2,1;307,1;309	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6060	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3514	215.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1784	1786	CCG	262;262;263	C,G,T;C;G,A	260,1,1;262;262,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2440	porA	1146	1146	99.65	porA.l15.c30.ctg.1	2439	124.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	703	705	GGC	178;177;176	G,A;G,C;C	177,1;176,1;176	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2440	porA	1146	1146	99.65	porA.l15.c30.ctg.1	2439	124.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	885	885	C	184	C	184	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4030	porB1b	1047	1047	99.81	porB1b.l6.c17.ctg.1	1699	286.8	0	.	p	.	0	G120D	NONSYN	358	360	GGC	870	872	GAC	349;353;354	G;A;C	349;353;354	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4030	porB1b	1047	1047	99.81	porB1b.l6.c17.ctg.1	1699	286.8	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	873	875	AAC	356;357;352	A,T;A;C	355,1;357;352	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	13658	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5348	318.8	0	.	p	.	0	N864K	NONSYN	2590	2592	AAT	3088	3090	AAA	363;362;359	A;A;A	363;362;359	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	13658	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5348	318.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2155	2157	CAT	366;369;370	C;A;T	366;369;370	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1932	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1526	158.0	1	SNP	p	V57M	0	.	.	169	171	GTG	749	751	GTG	348;350;351	G;T;G	348;350;351	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
